| Jonica C Calkins, MD | |
|
2025 Morse Ave, Sacramento, CA 95825-2115 | |
| (916) 973-5000 | |
| Not Available |
| Full Name | Jonica C Calkins |
|---|---|
| Gender | Female |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 26 Years |
| Location | 2025 Morse Ave, Sacramento, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124106844 | NPI | - | NPPES |
| 00A707240 | Medicaid | CA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | A70724 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Kaiser Foundation Hospital - Sacramento | Sacramento, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) in whom anticoagulation is appropriate, marking the second approval of this new oral anticoagulant following the recent marketing authorisation by the US Food and Drug Administration (FDA).
Scientists from the University of Surrey have identified mutations in a gene in an Escherichia coli (E. coli) model that could help explain a form of anti-microbial resistance (AMR) known as 'persistence'.
As food and pharmaceutical manufacturers strive to ensure maximum efficiency on their processing lines to maintain competitiveness, the X36 Series from Mettler-Toledo Safeline X-ray can help. This series of adaptable x-ray inspection systems uses the most advanced imaging technology on the market to provide high-detection sensitivity appropriate to a broad range of packaged applications.
Chemotherapy and radiation therapy are often used to kill cancer cells by causing irreparable DNA damage. However, some cancer patients resist chemotherapy and radiation due to a highly active DNA damage repair system.
With there being a concern that mastectomy is excessively used as a treatment for breast cancer, a survey of nearly 2,000 women indicates that breast-conserving surgery was attempted as the initial therapy for about 75 percent of those surveyed, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.
› Verified 1 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) in whom anticoagulation is appropriate, marking the second approval of this new oral anticoagulant following the recent marketing authorisation by the US Food and Drug Administration (FDA).
Scientists from the University of Surrey have identified mutations in a gene in an Escherichia coli (E. coli) model that could help explain a form of anti-microbial resistance (AMR) known as 'persistence'.
As food and pharmaceutical manufacturers strive to ensure maximum efficiency on their processing lines to maintain competitiveness, the X36 Series from Mettler-Toledo Safeline X-ray can help. This series of adaptable x-ray inspection systems uses the most advanced imaging technology on the market to provide high-detection sensitivity appropriate to a broad range of packaged applications.
Chemotherapy and radiation therapy are often used to kill cancer cells by causing irreparable DNA damage. However, some cancer patients resist chemotherapy and radiation due to a highly active DNA damage repair system.
With there being a concern that mastectomy is excessively used as a treatment for breast cancer, a survey of nearly 2,000 women indicates that breast-conserving surgery was attempted as the initial therapy for about 75 percent of those surveyed, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonica C Calkins, MD 1800 Harrison St Fl 7, Oakland, CA 94612-3466 Ph: (510) 625-6262 | Jonica C Calkins, MD 2025 Morse Ave, Sacramento, CA 95825-2115 Ph: (916) 973-5000 |
News Archive
Health Canada, the Canadian health authority, has approved PRADAX™ (dabigatran etexilate), Boehringer Ingelheim's novel, oral direct thrombin inhibitor for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF) in whom anticoagulation is appropriate, marking the second approval of this new oral anticoagulant following the recent marketing authorisation by the US Food and Drug Administration (FDA).
Scientists from the University of Surrey have identified mutations in a gene in an Escherichia coli (E. coli) model that could help explain a form of anti-microbial resistance (AMR) known as 'persistence'.
As food and pharmaceutical manufacturers strive to ensure maximum efficiency on their processing lines to maintain competitiveness, the X36 Series from Mettler-Toledo Safeline X-ray can help. This series of adaptable x-ray inspection systems uses the most advanced imaging technology on the market to provide high-detection sensitivity appropriate to a broad range of packaged applications.
Chemotherapy and radiation therapy are often used to kill cancer cells by causing irreparable DNA damage. However, some cancer patients resist chemotherapy and radiation due to a highly active DNA damage repair system.
With there being a concern that mastectomy is excessively used as a treatment for breast cancer, a survey of nearly 2,000 women indicates that breast-conserving surgery was attempted as the initial therapy for about 75 percent of those surveyed, according to a study in the October 14 issue of JAMA, a theme issue on surgical care.
› Verified 1 days ago
Vinod Trivedi, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1508 Alhambra Blvd Ste 200, Sacramento, CA 95816 Phone: 916-325-1040 Fax: 916-669-4100 | |
Patrick Richards, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3000 Q St, Sacramento, CA 95816 Phone: 916-733-3346 Fax: 916-733-3320 | |
Betty Carolyn Murray, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3000 Q St Fl 3, Sacramento, CA 95816 Phone: 916-733-3400 Fax: 916-733-5384 | |
Stephanie T Le, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3301 C St Ste 1400, Sacramento, CA 95816 Phone: 916-734-6111 Fax: 916-731-7183 | |
Kathryn D Newell, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4860 Y St, Suite 0101, Sacramento, CA 95817 Phone: 916-734-4843 Fax: 916-734-2732 | |
Dr. Michael John Thornton, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4150 V St, Suite 3400, Sacramento, CA 95817 Phone: 916-734-3566 | |
Dr. Pouria Kashkouli, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 4150 V St, #3116, Sacramento, CA 95817 Phone: 916-734-7080 |